Notably, PCSK9 expression is markedly elevated in T2DM and has been shown to correlate positively with major adverse cardiovascular events (MACEs), suggesting its potential pathogenic involvement in DCM warrants further investigation. This evidence concerns the gene PCSK9 and familial dilated cardiomyopathy.